Clinical Trial Update: Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events

View source ↗

Summary

A clinical trial is evaluating molecular features of acute myeloid leukemia patients after stem cell transplant to understand relapse events; the study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Center for International Blood and Marrow Transplant Research | Conditions: Acute Myeloid Leukemia in Remission | Status: ACTIVE_NOT_RECRUITING